Objective Research and development of a new microcapsule contrast agent with unique properties for MRI of both, the blood pool and internal organs. This dual agent approach allows patients to receive quicker and more convenient diagnosis, earlier disease detection and significantly reduces health care spending. The current problem relates to multiple and cost-& time intensive diagnosis - intended to be reduced to a 'one step diagnosis' by this new technology. Within the Craft project (step 2) we expect to develop a contrast agent suitable for the initial stages of clinical testing. Expertise and know-how of the Imaging market is available within the SME consortium. A suitable company (RTD performer) with the required know-how of the microcapsule spray dry technology is already identified. Fields of science engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Topic(s) 1.1.1.-3. - Key action The "Cell factory" Call for proposal Data not available Funding Scheme EAW - Exploratory awards Coordinator GOLDHAM BIOGLAN PHARMA GMBH EU contribution No data Address Am Wasserberg 11 86441 ZUSMARSHAUSEN Germany See on map Total cost No data Participants (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all SANOCHEMIA PHARMAZEUTIKA AG Austria EU contribution No data Address Boltzmanng-11 1090 WIEN See on map Total cost No data